Feed / RDNT

RadNet, Inc.

RDNT

Healthcare · 74.27 +4.8% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

RadNet, Inc.'s current read is isolated; its market group is not confirming.

The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.

What changed
  • Revenue increased 22.1% versus the comparable filing period.
  • Cash declined 262.0M versus the comparable period.
Company+4.8% todayVolume comparison unavailable
Market group0 of 1 activeOutpatient Diagnostic Imaging · unavailable
Disclosed network0 of 7 confirmingNo filing-linked name is confirming now
What would change this read
  • RDNT's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if RDNT's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Diagnostics & Research

The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.

Evidence that supports
  • Revenue increased 22.1% versus the comparable filing period.
  • The operating loss narrowed by 198,000.00.
Evidence that challenges
  • Cash declined 262.0M versus the comparable period.
What would clarify the read
  • RDNT's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations327
Usable filing statements105
Verified relationships7
Evidence supporting the case
  • Latest annual revenue changed +11.5% year over year.
Evidence challenging the case
  • Operating margin changed -2.7 percentage points in the latest annual period.
  • Net margin changed -1.1 percentage points in the latest annual period.
Questions before a position
  • EV/sales is 63% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 10, 2026

74.27
6m+21.4%12m+1.6%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$1.3B+22.7%$0.46+5.0%
2022-12-31$1.4B+8.7%$0.17+7.3%
2023-12-31$1.6B+13.0%$0.05+12.8%
2024-12-31$1.8B+13.2%$0.04+15.6%
2025-12-31$2.0B+11.5%$-0.25+0.6%

What management says matters

Persistent and emerging business drivers

Credit and interest ratesmixed · 4 filings
The increase was primarily attributable to higher incremental term loan borrowings in 2026, partially offset by the repayment of notes payable assumed in connection with acquisitions.
10-Q · Aug 10, 2026
Restructuring and cost reductionspositive · 4 filings
Other income for the nine months ended September 30, 2024 included money market interest income of $22.7 million, partially offset by an impairment of non-marketable securities of $1.2 million and debt extinguishment and restructuring charges of $8.9 million,…
10-Q · Nov 10, 2025
Demand and volumenegative · 3 filings
Industry Trends We believe the diagnostic imaging services industry will continue to grow as a result of a number of factors, including the following: Escalating Demand for Healthcare Services from an Aging Population.
10-K · Mar 2, 2026
Capital investment and capacitymixed · 2 filings
The increase was primarily due to a $28.7 million increase in purchases of imaging facilities and other acquisitions, $2.7 million increase in equity contributions to and purchases of interests in joint ventures, and a $17.1 million increase in capital expend…
10-Q · Nov 10, 2025

Valuation discipline

Descriptive valuation snapshot

Price/sales 2.7× · EV/sales 2.9×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

74.27+4.8% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for RDNT. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

The latest filing presents a mixed picture

10-Q filed 2026-05-11 against the comparable filing from 2025-05-12.

mixed
OperationsconstructiveEvidence score +3
liquiditycautiousEvidence score -1
valuationdiscount

What improved

  • Revenue increased 22.1% versus the comparable filing period.
  • The operating loss narrowed by 198,000.00.

What weakened

  • Cash declined 262.0M versus the comparable period.

Filing receipts

Interest expense In Thousands Three Months Ended March 31, Interest expense 2026 2025 $ Increase/(Decrease) % Change Total interest expense $ 17,657 $ 17,239 $418 2.4 % Interest related to derivatives* — (1,018) Interest expense related to amortization** 779 728 Adjusted interest expense*** 16,878 17,529 (651) (3.7) % *Includes payments from 2019 Swaps (as defined in the notes to our condensed consolidated financial statements) and Swaps amortization **Includes noncash amortization of deferred loan costs and discount on issuance of debt ***Includes interest related to our term loans, revolving credit line, notes, and other The decrease in interest expense was primarily driven by a lower ave...

The increase in professional fees relative to the 8.9% increase in same-center sales was primarily driven by (i) a greater mix of advanced imaging procedures, for which professional fees generally represent a higher proportion of revenue, and (ii) disproportionately higher growth in California imaging centers staffed by BRMG radiologists, whose professional fees are consolidated within our financial results.

Building and equipment rental In Thousands Three Months Ended March 31, Building & Equipment Rental 2026 2025 $ Increase % Change Total $35,832 $30,924 $4,908 15.9% Same Center $31,391 $30,863 $528 1.7% Excluded $4,441 $61 — — Building and equipment rental expense on a same-center basis increased slightly, primarily due to higher rent and common area maintenance charges.

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind RDNT

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ATMPFiling-linked namepartnerNov 10, 2025

1 to the Barclays Credit Agreement (the “First Amendment”) with the Barclays Bank Plc and the lenders and financial institutions named therein.

BCSBarclays PLCpartnerAug 11, 2025

Secured Credit Facilities We maintain secured credit facilities with Barclays and with Truist Bank.

Depended on by

ASTHAstrana Health, Inc.competitorMar 12, 2026

Outpatient Clinics Our outpatient clinics compete with large ambulatory surgery centers and/or diagnostic centers such as RadNet and Envision Healthcare, many of which have greater financial, personnel, and other resources, as well as smaller clinics with tie…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

RDNT is currently a Leader in the organic co-movement group Outpatient Diagnostic Imaging. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for RDNT; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.